Caffeine and Sodium Citrate Ingestion

Sponsor
Swiss Paraplegic Centre Nottwil (Other)
Overall Status
Completed
CT.gov ID
NCT01591226
Collaborator
(none)
9
1
4
7
1.3

Study Details

Study Description

Brief Summary

A positive ergogenic effect of sodium citrate and caffeine ingestion in a short-term, high-intensity exercise task was shown by several studies. These studies were conducted with healthy, able-bodied subjects.

The aim of the study is to investigate whether caffeine or sodium citrate ingestion could enhance performance in spinal cord injured wheelchair athletes. It is a double blind, placebo controlled and randomized study.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Caffeine
  • Dietary Supplement: Sodium Citrate
  • Dietary Supplement: Mannitol
  • Dietary Supplement: Sodium Chloride
N/A

Detailed Description

The athletes have to complete four 1500m tests on a training roller. Before each treatment they get different supplementations. Once they get sodium citrate and a placebo, once caffeine and a placebo, once sodium citrate and caffeine and for the fourth treatment they get twice a placebo. Two hours after starting with the supplementation they have to complete the 1500m as fast as possible. Time to complete 1500m, blood pH, plasma bicarbonate, sodium concentration, heart rate, oxygen consumption, blood lactate concentration and rate of perceived exertion (RPE) were measured.

Study Design

Study Type:
Interventional
Actual Enrollment :
9 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of Caffeine and Sodium Citrate Ingestion in 1500m Wheelchair Racing Athletes
Study Start Date :
Feb 1, 2012
Actual Primary Completion Date :
Sep 1, 2012
Actual Study Completion Date :
Sep 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Caffeine

6mg per kg bodyweight ingested 60min before test

Dietary Supplement: Caffeine
gelatine capsule 6mg/kg bodyweight 60min prior test

Dietary Supplement: Sodium Chloride
sodium chloride diluted in 7dl water 0.045g/kg bodyweight 120-90min prior test

Placebo Comparator: Placebo

Sodium chloride and mannitol as placebo are ingested by the athlete

Dietary Supplement: Mannitol
gelatine capsule filled with mannitol (100mg per capsule) ingested 60min prior test

Dietary Supplement: Sodium Chloride
sodium chloride diluted in 7dl water 0.045g/kg bodyweight 120-90min prior test

Active Comparator: Sodium Citrate

sodium citrate diluted in 7dl water, ingestion 120 to 90min prior test

Dietary Supplement: Sodium Citrate
0.5g/kg bodyweight diluted in 7dl water ingested 120-90min prior test

Dietary Supplement: Mannitol
gelatine capsule filled with mannitol (100mg per capsule) ingested 60min prior test

Active Comparator: Caffeine and Sodium Citrate

sodium citrate 120-90min prior test capsules:60min prior test

Dietary Supplement: Caffeine
gelatine capsule 6mg/kg bodyweight 60min prior test

Dietary Supplement: Sodium Citrate
0.5g/kg bodyweight diluted in 7dl water ingested 120-90min prior test

Outcome Measures

Primary Outcome Measures

  1. Time [3 weeks]

    Time to complete 1500m

Secondary Outcome Measures

  1. Heart Rate [during study phase of 3 week (4 tests)]

    Heart Rate measured from 2min before the test until 5min after the 1500m-test.

  2. Lactate Concentration [during the 3 weeks study phase]

    1min before starting the warm up, 15s after the end of the warm up, 15s after completing the test, 2min/4min/6min/8min/10min after the test

  3. blood pH, sodium concentration and plasma bicarbonate [during the 3 weeks of study phase]

    1min before starting with the ingestion of the fluid, immediately before starting the warm up, just immediately before starting the 1500m test.

  4. Oxygen Consumption [during 3 weeks of study phase]

    oxygen consumption (VO2(ml/min/kg), VCO2(ml/min), RER (VCO2/VO2)) starting of the measurement is 2min before the start of the 1500m and ends 2min after having completed the 1500m

  5. rating of gastrointestinal stress [during the 3 weeks of study phase]

    1min before starting to drink the fluid, 2min before starting with the warm up, 2min before the test and 2min after having completed the 1500m

  6. Rating of Perceived Exertion (RPE) [during the 3 weeks of study phase]

    15s after the end of the warm up, 15s after having completed the 1500m

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • wheelchair athletes

  • national team

  • category T53 and T54

Exclusion Criteria:
  • medicated

  • pregnant (for women)

  • cardiovascular and respiratory diseases

Contacts and Locations

Locations

Site City State Country Postal Code
1 Swiss Paraplegic Centre Nottwil Lucerne Switzerland 6207

Sponsors and Collaborators

  • Swiss Paraplegic Centre Nottwil

Investigators

  • Principal Investigator: Claudio Perret, Dr. sc. nat., Swiss Paraplegic Centre Nottwil

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Swiss Paraplegic Centre Nottwil
ClinicalTrials.gov Identifier:
NCT01591226
Other Study ID Numbers:
  • 2012-02
First Posted:
May 3, 2012
Last Update Posted:
Nov 22, 2016
Last Verified:
Nov 1, 2016
Keywords provided by Swiss Paraplegic Centre Nottwil
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 22, 2016